Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price on Dec 2, 2025

SONN Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
94583676
Market Cap Growth
242.32%-13.25%-38.41%-77.68%-51.75%1038.67%
Enterprise Value
8.354.332.945.358.9868.6
Last Close Price
1.266.6922.92258.461491.6912652.30
PS Ratio
3.41233.5733.9323.2775.42-
PB Ratio
--8.96-22.19-3.211.6425.03
P/TBV Ratio
-1.12-9.02-13.16-2.510.6716.02
EV/Sales Ratio
8.35232.5719.9215.2718.57-
Debt / Equity Ratio
-0.02-0.27-0.90-0.100.010.12
Asset Turnover
-0.000.030.020.030
Quick Ratio
0.180.280.550.464.121.56
Current Ratio
0.260.660.860.664.301.62
Return on Equity (ROE)
-3053.85%2089.93%1362.37%-301.42%-197.66%36739.16%
Return on Assets (ROA)
-326.04%-288.99%-333.81%-170.40%-135.65%-122.64%
Return on Invested Capital (ROIC)
-2232.90%-1558.83%-2651.49%-4153.91%-2860.72%-117.51%
Return on Capital Employed (ROCE)
-2970.96%4435.65%1546.77%-297.35%-196.30%-290.15%
Buyback Yield / Dilution
-469.85%-404.96%-425.71%-147.76%-160.57%-3409.64%
Total Shareholder Return
-469.85%-404.96%-425.71%-147.76%-160.57%-3409.64%
SEC Filings: 10-K · 10-Q